STOBIE ALAN

A compound of Formula (IA) or (IB), or a pharmaceutically acceptable salt, solvate (including hydrate) of said compound and salt, or a prodrug of said compound, or a pharmaceutically acceptable salt or solvate of said prodrug, Formula (IA),…

A compound of Formula (IA) or (IB), or a pharmaceutically acceptable salt, solvate (including hydrate) of said compound and salt, or a prodrug of said compound, or a pharmaceutically acceptable salt or solvate of said prodrug, Formula (IA),…

A compound of Formula (IA) or (IB), or a pharmaceutically acceptable salt, solvate (including hydrate) of said compound and salt, or a prodrug of said compound, or a pharmaceutically acceptable salt or solvate of said prodrug, Formula (IA),…

A compound of Formula (IA) or (IB), or a pharmaceutically acceptable salt, solvate (including hydrate) of said compound and salt, or a prodrug of said compound, or a pharmaceutically acceptable salt or solvate of said prodrug, Formula (IA),…

A compound of Formula (IA) or (IB), or a pharmaceutically acceptable salt, solvate (including hydrate) of said compound and salt, or a prodrug of said compound, or a pharmaceutically acceptable salt or solvate of said prodrug, Formula (IA),…

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…

Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; Rrepresents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; Rrepresents H…

or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy R1 and R2 independently represent hydrogen, halo or C1-6alkyl, ring A represents Het1 X repr…

or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy R1 and R2 independently represent hydrogen, halo or C1-6alkyl, ring A represents Het1 X repr…

or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy R1 and R2 independently represent hydrogen, halo or C1-6alkyl, ring A represents Het1 X repr…

or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy R1 and R2 independently represent hydrogen, halo or C1-6alkyl, ring A represents Het1 X repr…

or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy R1 and R2 independently represent hydrogen, halo or C1-6alkyl, ring A represents Het1 X repr…

Compounds of formula (I): or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy; R and R independently represent hydrogen, halo or C1-6alkyl, ring…

Compounds of formula (I): or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy; R and R independently represent hydrogen, halo or C1-6alkyl, ring…

Compounds of formula (I): or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy; R and R independently represent hydrogen, halo or C1-6alkyl, ring…

Compounds of formula (I): or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy; R and R independently represent hydrogen, halo or C1-6alkyl, ring…

Compounds of formula (I): or a pharmaceutically acceptable derivative thereof, wherein R represents C1-6alkyl (optionally substituted by C1-6alkyloxy or Het) or C1-6alkyloxy; R and R independently represent hydrogen, halo or C1-6alkyl, ring…